NCT06438250View on ClinicalTrials.gov

68Ga-JH04 PET/CT: Dosimetry and Biodistribution Studies

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

May 1, 2025

Study Completion Date

December 31, 2025

Conditions
Malignant Neoplasm
Interventions
DRUG

68Ga-JH04

The dose will be 148-222 MBq given intravenously.

Trial Locations (1)

350005

RECRUITING

Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University, Fuzhou

All Listed Sponsors
lead

First Affiliated Hospital of Fujian Medical University

OTHER